Get started
Author

Valentino Clemente

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
2020 · Valentino Clemente, Padraig D’Arcy, et al. · International Journal of Molecular Sciences · 62
PDF
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer
2024 · Emil Lou, Valentino Clemente, et al. · JAMA Network Open · 31
PDF
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
2021 · Xianonan Zhang, Mihir Shetty, et al. · International Journal of Molecular Sciences · 22
PDF
GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
2022 · Valentino Clemente, Asumi Hoshino, et al. · Cancer Research Communications · 15
The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol
2023 · Asumi Hoshino, Valentino Clemente, et al. · Journal of Biological Chemistry · 7
PDF
HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma
2025 · Victoria M. Ettorre, Luca Palmieri, et al. · Cells · 6
PDF
UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System
2021 · Valentino Clemente, Asumi Hoshino, et al. · Cells · 4
PDF
The Microtubule Severing Protein UNC-45A Counteracts the Microtubule Straightening Effects of Taxol
2023 · Asumi Hoshino, Valentino Clemente, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction
2023 · Emil Lou, Valentino Clemente, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Bioenergetic and Proteomic Profiling of ARID1A-Deficient Ovarian Clear Cell Carcinoma under Metabolic Challenge
2026 · Harith A. Ismail, Kristina Dankova, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Review of: "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity"
2023 · Valentino Clemente · Qeios
PDF
Data from GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
2023 · Valentino Clemente, Asumi Hoshino, et al.
Data from GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
2023 · Valentino Clemente, Asumi Hoshino, et al.
Supplementary Figures S1, Tables S1-S2 from GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
2023 · Valentino Clemente, Asumi Hoshino, et al.
Supplementary Figures S1, Tables S1-S2 from GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
2023 · Valentino Clemente, Asumi Hoshino, et al.
PDF
GLS1 is a protective factor rather than a molecular target in ARID1A-mutated ovarian clear cell carcinoma
2021 · Valentino Clemente, Andrew Nelson, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 16
Citation count: 150
H-index: 6
I10-index: 4
Year
Topic
Type